|
1
|
Hirschfeld J: Neutrophil subsets in
periodontal health and disease: A mini review. Front Immunol.
10(3001)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Takahashi N, Okui T, Tabeta K and Yamazaki
K: Effect of interleukin-17 on the expression of chemokines in
gingival epithelial cells. Eur J Oral Sci. 119:339–344.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tipton DA, Cho S, Zacharia N and Dabbous
MK: Inhibition of interleukin-17-stimulated interleukin-6 and -8
production by cranberry components in human gingival fibroblasts
and epithelial cells. J Periodontal Res. 48:638–646.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dutzan N and Abusleme L: T helper 17 cells
as pathogenic drivers of periodontitis. Adv Exp Med Biol.
1197:107–117. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rot A and von Andrian UH: Chemokines in
innate and adaptive host defense: Basic chemokinese grammar for
immune cells. Ann Rev Immunol. 22:891–928. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lindhe J and Nyman S: Scaling and
granulation tissue removal in periodontal therapy. J Clin
Periodontol. 12:374–388. 1985.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Graziani F, Karapetsa D, Alonso B and
Herrera D: Nonsurgical and surgical treatment of periodontitis: How
many options for one disease? Periodontology. 75:152–188.
2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kitamura M, Akamatsu M, Machigashira M,
Hara Y, Sakagami R, Hirofuji T, Hamachi T, Maeda K, Yokota M, Kido
J, et al: FGF-2 stimulates periodontal regeneration: Results of a
multi-center randomized clinical trial. J Dent Res. 90:35–40.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
da Costa LF, Amaral CD, Barbirato DD, Leão
AT and Fogacci MF: Chlorhexidine mouthwash as an adjunct to
mechanical therapy in chronic periodontitis: A meta-analysis. J Am
Dent Assoc. 148:308–318. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Matesanz-Pérez P, García-Gargallo M,
Figuero E, Bascones-Martínez A, Sanz M and Herrera D: A systematic
review on the effects of local antimicrobials as adjuncts to
subgingival debridement, compared with subgingival debridement
alone, in the treatment of chronic periodontitis. J Clin
Periodontol. 40:227–241. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nakano K, Higashi T, Hashimoto K, Takagi
R, Tanaka Y and Matsushita S: Antagonizing dopamine D1-like
receptor inhibits Th17 cell differentiation: Preventive and
therapeutic effects on experimental autoimmune encephalomyelitis.
Biochem Biophys Res Commun. 373:286–291. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nakano K, Yamaoka K, Hanami K, Saito K,
Sasaguri Y, Yanagihara N, Tanaka S, Katsuki I, Matsushita S and
Tanaka Y: Dopamine induces IL-6-dependent IL-17 production via
D1-like receptor on CD4 naive T cells and D1-like receptor
antagonist SCH-23390 inhibits cartilage destruction in a human
rheumatoid arthritis/SCID mouse chimera model. J Immunol.
186:3745–3752. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Missale C, Nash SR, Robinson SW, Jaber M
and Caron MG: Dopamine receptors: From structure to function.
Physiol Rev. 78:189–225. 1998.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Okada H, Inoue T, Hashimoto K, Suzuki H
and Matsushita S: . D1-like receptor antagonist inhibits IL-17
expression and attenuates crescent formation in nephrotoxic serum
nephritis. Am J Nephrol. 30:274–279. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hashimoto K, Inoue T, Higashi T, Takei S,
Awata T, Katayama S, Takagi R, Okada H and Matsushita S: Dopamine
D1-like receptor antagonist, SCH23390, exhibits a preventive effect
on diabetes mellitus that occurs naturally in NOD mice. Biochem
Biophys Res Comm. 383:460–463. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pelletier M, Maggi L, Micheletti A,
Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato
F, Romagnani S and Cassatella MA: Evidence for a cross-talk between
human neutrophils and Th17 cells. Blood. 115:335–343.
2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Matsuyama T, Kawano M, Takagi R, Nakagome
K, Chikamatsu K and Matsushita S: Interleukin-8 produced by T cells
is under the control of dopamine signaling. Clin Exp Neuroimmunol.
9:2571–2257. 2018.
|
|
18
|
Parrado AC, Canellada A, Gentile T and
Rey-Roldán EB: Dopamine agonists upregulate IL-6 and IL-8
production in human keratinocytes. Neuroimmunomodulation.
19:359–366. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kawano M, Saika K, Takagi R, Matsui M and
Matsushita S: Tannic acid acts as an agonist of the dopamine D2L
receptor, regulates immune responses, and ameliorates
experimentally induced colitis in mice. Brain Behav Immun Health.
5(100071)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Takagi R, Kawano M, Sato T and Matsushita
S: Tannic acid, a dopamine receptor agonist, ameliorates
periodontitis, atopic dermatitis and psoriasis in animal models.
Curr Trends Immunol. 22:11–17. 2021.
|
|
21
|
Chen S, Zhang X, Yang D, Du Y, Li L, Li X,
Ming M and Le W: D2/D3 receptor agonist ropinirole protects
dopaminergic cell line against rotenone-induced apoptosis through
inhibition of caspase- and JNK-dependent pathways. FEBS Lett.
582:603–610. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hatakeyama S, Ohara-Nemoto Y, Yanai N,
Obinata M, Hayashi S and Satoh M: Establishment of gingival
epithelial cell lines from transgenic mice harboring temperature
sensitive simian virus 40 large T-antigen gene. J Oral Pathol Med.
30:296–304. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kirihara Y, Takechi M, Kurosaki K,
Kobayashi Y, Saito Y and Takeuchi T: Effects of an anesthetic
mixture of medetomidine, midazolam, and butorphanol in rats-strain
difference and antagonism by atipamezole. Exp Anim. 65:27–36.
2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nakamura T, Ichii O, Irie T, Hosotani M,
Dantsuka A, Nakamura S, Sato S, Sotozaki K, Kouguchi H, Yoshiyasu
T, et al: Usefulness of an anesthetic mixture of medetomidine,
midazolam, and butorphanol in cotton rats (Sigmodn hispidus). Jpn J
Vet Res. 64:273–276. 2016.PubMed/NCBI
|
|
25
|
Bellini L, Banzato T, Contiero B and Zotti
A: Evaluation of three medetomidine-based protocols for chemical
restraint and sedation for non-painful procedures in companion rats
(Rattus norvegicus). Vet J. 200:456–458. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yoshida K, Murakawa M and Hosono A:
Effects of anesthetics on expression of dopamine and acetylcholine
receptors in the rat brain in vivo. J Anesth. 36:436–440.
2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yamamoto H, Yokoyama M, Tamura H, Okumura
S, Kawada E and Kuboyama N: Carrageenin-induced periodontitis as an
experimental model in rats analyzed by micro-computerized
tomography. J Hard Tissue Biol. 20:231–236. 2011.
|
|
28
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mukaida N, Harada A and Matsushima K:
Interleukin-8 (IL-8) and monocyte chemotactic and activating factor
(MCAF/MCP-1), chemokines essentially involved in inflammatory and
immune reactions. Cytokine Growth Factor Rev. 9:9–23.
1998.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Borthakur A, Bhattacharyya S, Dudeja PK
and Tobacman JK: Carrageenan induces interleukin-8 production
through distinct Bcl10 pathway in normal human colonic epithelial
cells. Am J Physiol Gastrointest Liver Physiol. 292:G829–G838.
2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Mitani A, Niedbala W, Fujimura T, Mogi M,
Miyamae S, Higuchi N, Abe A, Hishikawa T, Mizutani M, Ishihara Y,
et al: Increased expression of interleukin (IL)-35 and IL-17, but
not IL-27, in gingival tissues with chronic periodontitis. J
Periodontol. 86:301–309. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Franco R, Reyes-Resina I and Navarro G:
Dopamine in health and disease: Much more than a neurotransmitter.
Biomedicines. 9(109)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nakagome K, Imamura M, Okada H, Kawahata
K, Inoue T, Hashimoto K, Harada H, Higashi T, Takagi R, Nakano K,
et al: Dopamine D1-like receptor antagonist attenuates
Th17-mediated immune response and ovalbumin antigen-induced
neutrophilic airway inflammation. J Immunol. 186:5975–5982.
2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lu JH, Liu YQ, Deng QW, Peng YP and Qiu
YH: Dopamine D2 receptor is involved in alleviation of type II
collagen-induced arthritis in mice. BioMed Res Int.
2015(496759)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lieberknecht V, Junqueira SC, Cunha MP,
Barbosa TA, de Souza LF, Coelho IS, Santos AR, Rodrigues AL, Dafré
AL and Dutra RC: Pramipexole, a dopamine D2/D3 receptor-preferring
agonist, prevents experimental autoimmune encephalomyelitis
development in mice. Mol Neurobiol. 54:1033–1045. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cheng WC, Hughes FJ and Taams LS: The
presence, function and regulation of IL-17 and Th17 cells in
periodontitis. J Clin Periodontol. 41:541–549. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tsukasaki M, Komatsu N, Nagashima K, Nitta
T, Pluemsakunthai W, Shukunami C, Iwakura Y, Nakashima T, Okamoto K
and Takayanagi H: Host defense against oral microbiota by
bone-damaging T cells. Nat Commun. 9(701)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kuzel MD: Ropinirole: A dopamine agonist
for the treatment of parkinson's disease. Am J Health Syst Pharm.
56:217–224. 1999.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pradeep AR, Singh SP, Martande SS, Raju
AP, Rustagi T, Suke DK and Naik SB: Clinical evaluation of the
periodontal health condition and oral health awareness in
parkinson's disease patients. Gerodontology. 32:100–106.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Schwarz J, Heimhilger E and Storch A:
Increased periodontal pathology in parkinson's disease. J Neurol.
253:608–611. 2006.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Einarsdóttir ER, Gunnsteinsdóttir H,
Hallsdóttir MH, Sveinsson S, Jónsdóttir SR, Olafsson VG, Bragason
TH, Saemundsson SR and Holbrook WP: Dental health of patients with
parkinson's disease in Iceland. Spec Care Dentist. 29:123–127.
2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hanaoka A and Kashihara K: Increased
frequencies of caries, periodontal disease and tooth loss in
patients with parkinson's disease. J Clin Neurosci. 16:1279–1282.
2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Armstrong MJ and Okun MS: Diagnosis and
treatment of parkinson disease: A review. JAMA. 323:548–560.
2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
de Molon RS, Mascarenhas VI, de Avila ED,
Finoti LS, Toffoli GB, Spolidorio DM, Scarel-Caminaga RM, Tetradis
S and Cirelli JA: Long-term evaluation of oral gavage with
periodontopathogens or ligature induction of experimental
periodontal disease in mice. Clin Oral Invest. 20:1203–1216.
2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Barth CR, Funchal GA, Luft C, de Oliveira
JR, Porto BN and Donadio MV: Carrageenan-induced inflammation
promotes ROS generation and neutrophil extracellular trap formation
in a mouse model of peritonitis. Eur J Immunol. 46:964–970.
2016.PubMed/NCBI View Article : Google Scholar
|
